|
bodipy |
5 |
|
bone regeneration |
5 |
|
calcitonin gene-related peptide |
5 |
|
diabetes-related periodontitis |
5 |
|
pamam |
5 |
|
photodynamic therapy |
5 |
|
retinoblastoma |
5 |
|
ros-responsive hydrogel |
5 |
|
sensory nerve |
5 |
|
type h vessels |
5 |
|
cancer immunotherapy |
4 |
|
hybrid exosomes |
4 |
|
immunotherapy |
4 |
|
light-triggered drug release |
4 |
|
photoimmunotherapy |
4 |
|
photosensitive nanoparticles |
4 |
|
self-assembly |
4 |
|
γδ-t exosomes |
4 |
|
charge reversal |
3 |
|
ferroptosis |
3 |
|
ocular drug delivery |
3 |
|
phototargeting |
3 |
|
trigonal small molecules |
3 |
|
aggregation-induced emission |
2 |
|
antibiotics |
2 |
|
antifungal |
2 |
|
bacteria |
2 |
|
cancer therapy |
2 |
|
cell membrane-coated nanoparticles |
2 |
|
chemotherapy |
2 |
|
coumarin |
2 |
|
depegylation |
2 |
|
drug delivery |
2 |
|
drug release |
2 |
|
electroconductive microneedle |
2 |
|
fluorescent probe |
2 |
|
gold nanorod |
2 |
|
homotyic targeting |
2 |
|
infected wound healing |
2 |
|
intraocular drug delivery |
2 |
|
intravitreal injection |
2 |
|
liposome |
2 |
|
local anesthesia |
2 |
|
nanomedicine |
2 |
|
neuro-immune crosstalk |
2 |
|
nucleus targeting |
2 |
|
outer membrane vesicle |
2 |
|
photocleavage |
2 |
|
photon upconversion |
2 |
|
photoresponsive nanoparticles |
2 |
|
photoresponsive prodrugs |
2 |
|
photothermal therapy |
2 |
|
phototriggering |
2 |
|
stimuli-responsive drug delivery |
2 |
|
targeted drug delivery |
2 |
|
tetrodotoxin |
2 |
|
age-related macular degeneration |
1 |
|
amino acid starvation |
1 |
|
amino acids |
1 |
|
ammonia |
1 |
|
anti-angiogenesis |
1 |
|
aptamer |
1 |
|
aromatic interactions |
1 |
|
atherosclerosis |
1 |
|
au nanoshells |
1 |
|
autocatalytic reaction |
1 |
|
autophagy |
1 |
|
bioavailability |
1 |
|
biological barriers |
1 |
|
biomedical applications |
1 |
|
biosensors |
1 |
|
black phosphorus |
1 |
|
building blockes |
1 |
|
bupivacaine |
1 |
|
caged ligands |
1 |
|
cancer cell stemness |
1 |
|
cancer starvation therapy |
1 |
|
cancer stem-like cell |
1 |
|
cancer stemness |
1 |
|
cancer targeting |
1 |
|
cancer theranostics |
1 |
|
cancer treatment |
1 |
|
carbon dioxide |
1 |
|
carrier-free |
1 |
|
carrier-free nanoparticles |
1 |
|
carvedilol |
1 |
|
cavitation |
1 |
|
cdk4/6 |
1 |
|
cell cycle |
1 |
|
cell death |
1 |
|
cell-mediated drug delivery |
1 |
|
cellular targeting |
1 |
|
chemistry |
1 |
|
chitosan |
1 |
|
chlorin e6 (ce6) |
1 |
|
choroidal neovascularization (cnv) |
1 |
|
clathrins |
1 |
|
combretastatin a-4 |
1 |
|
concanavalin a |
1 |
|
cyanine prodrug |
1 |
|
dasatinib |
1 |
|
dexmedetomidine |
1 |
|
dextran sulfate |
1 |
|
dimeric prodrug |
1 |
|
drug dissolution |
1 |
|
endocytosis |
1 |
|
endothermic |
1 |
|
energy transfer |
1 |
|
epigenetic regulation |
1 |
|
external stimuli |
1 |
|
extracellular matrix |
1 |
|
extracellular vesicle |
1 |
|
eyedrops |
1 |
|
fluorescent probes |
1 |
|
folic acid |
1 |
|
glycan |
1 |
|
glycosaminoglycan |
1 |
|
hydroxyl radical probes |
1 |
|
hypoxia |
1 |
|
hypoxia-stimulus |
1 |
|
immunogenic cell death |
1 |
|
immunoglobulin |
1 |
|
immunoregulatory nanomedicine |
1 |
|
inflammatory bowel disease |
1 |
|
intravenous regional anesthesia |
1 |
|
issue 95 |
1 |
|
light |
1 |
|
light responsiveness |
1 |
|
light triggering |
1 |
|
light-responsive nanoparticles |
1 |
|
long-wavelength light excitation |
1 |
|
long‐wavelength light triggering |
1 |
|
macrophage immunotherapy |
1 |
|
macropinocytosis |
1 |
|
manganese dioxide |
1 |
|
metal-shell dielectric-core nanoparticles |
1 |
|
micelle |
1 |
|
molecular design |
1 |
|
mtor inhibition |
1 |
|
nano-assemblies |
1 |
|
nanocarriers |
1 |
|
nanomedicines |
1 |
|
nanoparticle |
1 |
|
nanoparticles |
1 |
|
nanospheres |
1 |
|
natural igm |
1 |
|
near infrared |
1 |
|
near-infrared (nir) light-activation |
1 |
|
near-infrared absorption |
1 |
|
nir light |
1 |
|
noncovalent functionalization |
1 |
|
notch |
1 |
|
notch pathway |
1 |
|
ocular anesthesia |
1 |
|
organoid culture system |
1 |
|
oxidation therapy |
1 |
|
oxygen self-supply |
1 |
|
ph-dependent solubility |
1 |
|
ph-responsive polymersomes |
1 |
|
photochemical reaction |
1 |
|
photocleavable groups |
1 |
|
photocleavable protecting groups |
1 |
|
photocleavages |
1 |
|
photodynamic therapy (pdt) |
1 |
|
photopharmacology |
1 |
|
photorelease |
1 |
|
photoresponse |
1 |
|
photoresponsive |
1 |
|
photoresponsive binding |
1 |
|
photoresponsive drug delivery |
1 |
|
phototargeted |
1 |
|
phototargeted nanoparticles |
1 |
|
phototherapy |
1 |
|
pnipaam |
1 |
|
polyelectrolyte complex |
1 |
|
polymer prodrug |
1 |
|
polymeric nanoparticles |
1 |
|
polymersomes |
1 |
|
polysaccharide |
1 |
|
posterior segment eye diseases |
1 |
|
precipitation inhibitor |
1 |
|
prodrug |
1 |
|
protac |
1 |
|
reactive oxygen species |
1 |
|
reactive oxygen species (ros) |
1 |
|
red-light activation |
1 |
|
safety |
1 |
|
sdf-1α |
1 |
|
second harmonic generation imaging |
1 |
|
self-assembled nanoparticles |
1 |
|
shear-thinning |
1 |
|
shielding |
1 |
|
small molecule self-assembly |
1 |
|
specific targeting |
1 |
|
standardization |
1 |
|
steroid drugs |
1 |
|
stimuli-responsive nanoparticles |
1 |
|
supramolecular hydrogels |
1 |
|
synergistic effect |
1 |
|
temperature-responsive |
1 |
|
therapeutic nanoreactors |
1 |
|
three-legged molecules |
1 |
|
tolerogenic immunotherapy |
1 |
|
toxicity |
1 |
|
transdermal transport |
1 |
|
tumor microenvironment |
1 |
|
tumor organoids |
1 |
|
two-photon luminescence imaging |
1 |
|
ubiquitin-proteasome system |
1 |
|
upconverting micelles |
1 |
|
yigsr |
1 |
